Significant Revenue Growth
Inspire Medical Systems reported a total revenue of $239.7 million for Q4 2024, a 25% increase compared to Q4 2023. The full year revenue for 2024 was $802.8 million, a 28% increase over 2023.
First Full Year of Profitability
Inspire Medical Systems achieved its first full year of profitability in 2024, reporting a net income of $53.5 million compared to a net loss of $21.2 million in 2023.
Strong International Growth
Revenue outside the U.S. was $8.1 million for Q4 2024, marking a 163% increase year-over-year.
Positive Outlook and Guidance for 2025
The company expects full year 2025 revenue to be in the range of $940 million to $955 million, representing 17% to 19% growth year-over-year.
FDA Approval for Inspire V Neurostimulator
Received FDA approval for the Inspire V neurostimulation system designed to improve surgical efficiency and reduce complexity.